Showing 1 - 3 results of 3 for search 'Valle Recasens', query time: 0.03s Refine Results
  1. 1
    P1480: CLINICAL AND GENETIC STUDY OF HEREDITARY SPHEROCYTOSIS IN THE SPANISH POPULATION.

    P1480: CLINICAL AND GENETIC STUDY OF HEREDITARY SPHEROCYTOSIS IN THE SPANISH POPULATION. by Lucia Castilla, Jose Aspa, Jorge Martínez Nieto, Ángel Zúñiga Cabrera, Marta Santiago, Ana Garcia Feria, Josefa Esperanza Marco Buades, María Argüello Marina, Rosa María Ayala Diaz, Ricardo Sanchez, Rafael Del Orbe Barreto, Ana Lobo Olmedo, Julio Dávila-Valls, Sonia Martín-Pérez, Cristina Jativa Saez, Inés Hernández Rodriguez, Eduardo Salido, Valle Recasens, Lucía Guerrero Fernández, Maria Belén Moreno Risco, Ataulfo González Fernández, Montserrat Lopez Rubio

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).

    Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM). by Julia González-Rincón, José A Garcia-Vela, Sagrario Gómez, Belén Fernández-Cuevas, Sara Nova-Gurumeta, Nuria Pérez-Sanz, Miguel Alcoceba, Marcos González, Eduardo Anguita, Javier López-Jiménez, Eva González-Barca, Lucrecia Yáñez, Ernesto Pérez-Persona, Javier de la Serna, Miguel Fernández-Zarzoso, Guillermo Deben, Francisco J Peñalver, María C Fernández, Jaime Pérez de Oteyza, M Ángeles Andreu, M Ángeles Ruíz-Guinaldo, Raquel Paz-Arias, M Dolores García-Malo, Valle Recasens, Rosa Collado, Raúl Córdoba, Belén Navarro-Matilla, Margarita Sánchez-Beato, José A García-Marco

    Published 2021-01-01
    Get full text
    Article
  3. 3
    High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance

    High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and... by José A. García-Marco, Javier López Jiménez, Valle Recasens, Miguel Fernández Zarzoso, Eva González-Barca, Nieves Somolinos De Marcos, M. Jose Ramírez, Francisco Javier Peñalver Parraga, Lucrecia Yañez, Javier De La Serna Torroba, Maria Dolores Garcia Malo, Guillermo Deben Ariznavarreta, Ernesto Perez Persona, M. Angeles Ruiz Guinaldo, Raquel De Paz Arias, Elena Bañas Llanos, Isidro Jarque, M. del Carmen Fernandez Valle, Ana Carral Tatay, Jaime Perez De Oteyza, Eva Maria Donato Martin, Inmaculada Perez Fernández, Rafael Martinez Martinez, M. Angeles Andreu Costa, Diana Champ, Julio García Suarez, Marcos González Díaz, Secundino Ferrer, Félix Carbonell, José A. García-Vela

    Published 2019-11-01
    Get full text
    Article

Search Tools: